TTKHLTCAREBSETTK HEALTHCARE LIMITED· DiversifiedHighNeutral
Announced Thu, 23 Jul, 2026 · 12:53 IST

TTK Healthcare to sell EVA and Good Home brands to Wipro for Rs 256 cr

Core Business DivestedStrategic Transactions View source PDFExplain this filing

TTKHLTCARE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+1.4%Reaction day
₹1005.50
prior close
₹996.85
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.7%+2.1% vs market
Diversified peers, median of 12sector-0.5%+1.9% vs sector

On the reaction day the stock moved 2.1 pts more than Nifty Microcap 250 and 1.9 pts more than its Diversified peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+4.2
10m
+6.0
15m
+3.6
30m
+3.4
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+1.4-0.7+2.1-0.5+1.9
Next day
+4.2-0.3+4.5-0.4+4.6
2d
+6.6+1.1+5.6+0.5+6.1
3d
+5.3-0.2+5.5-0.9+6.2
4d
+3.5+0.2+3.3-1.1+4.7
5d
-0.5-0.3-0.2-2.4+1.8
1w
+4.2+2.1+2.1-0.3+4.5
15d
+13.8+4.6+9.2-1.4+15.2
1m
+9.4+5.6+3.8-3.1+12.5
2m
+4.5+7.2-2.7-3.6+8.2
3m
-2.5-4.7+2.1-11.8+9.3
UpDownMarket · Nifty Microcap 250Sector · Diversified peers, median of 12Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

TTK Healthcare board approved sale of its EVA and Good Home brands to Wipro Enterprises Private Limited for Rs 256 crores plus GST. These brands contributed around Rs 148 crores revenue (about 17 percent of total turnover) in FY 2025-26. Closing is expected by September 30, 2026, subject to customary conditions. Buyer is not from promoter group and the deal is not a related party transaction.

Likely market impact

Divests 17 percent of revenue base. Rs 256 cr proceeds may strengthen balance sheet and allow focus on core healthcare business. Watch for closing by September 2026.